Daniela Georgieva
About Daniela Georgieva
Daniela Georgieva is a Senior Scientist I at MOMA Therapeutics in Boston, Massachusetts, where she has worked since 2020. She holds a PhD in Cell and Molecular Biology from Columbia University and has a background in research at notable institutions, including Memorial Sloan-Kettering Cancer Center and Columbia University.
Work at MOMA Therapeutics
Daniela Georgieva has served as a Senior Scientist I at MOMA Therapeutics since 2020. She is based in Boston, Massachusetts, where she has contributed to the company's research initiatives for four years. Her role involves advancing scientific understanding and developing innovative therapeutic approaches.
Education and Expertise
Daniela Georgieva holds a Doctor of Philosophy (PhD) in Cell and Molecular Biology from Columbia University, where she studied from 2013 to 2019. Prior to her PhD, she earned a Bachelor of Science degree with a double major in Biology and Chemistry from Ramapo College of New Jersey from 2006 to 2010. Her educational background equips her with a strong foundation in biological sciences and research methodologies.
Background
Before joining MOMA Therapeutics, Daniela Georgieva worked as a Postdoctoral Research Scientist at Columbia University for nine months in 2019. She also gained experience as a Research Technician at Memorial Sloan-Kettering Cancer Center from 2010 to 2013. This diverse background in prestigious institutions has contributed to her expertise in scientific research.
Research Contributions
Daniela Georgieva has made significant contributions to scientific research, including the development of a novel method using nanopore sequencing to map DNA replication and repair sites. She has authored six publications in renowned peer-reviewed journals, demonstrating her commitment to advancing knowledge in her field.
Funding and Collaborations
Georgieva has played a key role in grant applications that have collectively secured over $1,000,000 in funding for research projects. She has also led the establishment of new research labs and facilitated collaborations between multiple academic institutions, enhancing research capabilities and fostering innovation.